Form 4: Natera Executive Exercises and Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
A Natera executive exercised stock options and sold shares to cover tax obligations, with sales prices ranging from $166.5937 to $166.5938 per share.
Summary
- A Natera executive, Solomon Moshkevich, exercised stock options to acquire 5,752 shares at $7.4491 per share and 3,323 shares at $12.8501 per share.
- The executive then sold 4,858 shares at a weighted average price of $166.5937 per share.
- The sale of shares was to satisfy tax withholding and remittance obligations related to the option exercises.
- The shares were sold in multiple transactions with prices ranging from $166.5937 to $166.5938 per share.
- The options shares are fully exercisable.
Sentiment
Score: 6
Explanation: The document describes a routine executive stock transaction for tax purposes. It is neither particularly positive nor negative for the company's outlook.
Positives
- The executive exercised options, indicating confidence in the company's future.
- The sale of shares was conducted to meet tax obligations, which is a normal practice.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, although this sale was for tax purposes.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, often related to compensation and tax planning. This transaction is not unusual and is in line with standard practices.
Comparison to Industry Standards
- Executive stock option exercises and subsequent sales to cover tax obligations are a common practice across the biotechnology and healthcare industries.
- Companies like Exact Sciences (EXAS) and Guardant Health (GH) also see similar transactions by their executives.
- The price range of the sale is within the expected range for a company of Natera's size and market capitalization.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine executive stock sale for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 2024-12-09 | Date of stock option exercises and share sales. |
| 2024-12-11 | Date of filing the transaction. |
| 2025-03-25 | Date of expiry of some of the stock options. |
| 2025-06-17 | Date of expiry of some of the stock options. |
Keywords
Natera, Stock Options, Share Sale, Executive Compensation, Tax Obligations, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.